Karlsruhe’s Städtisches Klinikum Karlsruhe will host a continuing medical education event focused on Hematology, Oncology & Palliative Medicine on January 22, 2026, from 5:00 PM to 7:30 PM in the Lecture Hall of Building D. The free event will feature presentations from leading specialists including Prof. Dr. Andreas Reiter of UMM Universitätsmedizin Mannheim, Prof. Dr. med. Mark Ringhoffer of Städtisches Klinikum Karlsruhe, and Dr. Michael Schatz of ViDia Kliniken Karlsruhe. The event has been submitted for certification to the State medical chamber of Baden-Württemberg for continuing medical education credits and is sponsored by 16 pharmaceutical companies, totaling €11,200 in financial support. registration is required by January 14, 2026, and can be completed via fax, email, or post, contacting Sonja Klopper-Sommer at the Secretariat of Medical Clinic III.
Karlsruhe, Germany – A comprehensive review of the latest advancements in hematology, presented at the American Society of Hematology’s annual meeting in Orlando, Florida, from December 6-9, 2025, highlights promising developments in the treatment of blood cancers and related disorders. The meeting, considered the largest and most comprehensive congress in the field, showcased breakthroughs in understanding genetic changes and the application of novel immunotherapies.
Key areas of focus included leukemias, lymphomas, multiple myeloma, and myeloproliferative neoplasms. Researchers presented clinical trial data demonstrating the potential of modern substances, such as bispecific antibodies, to improve the efficacy and safety of first-line therapies. Advances in cellular therapies, including CAR-T cells, were also a prominent feature of the conference, with presentations detailing methodological improvements aimed at enhancing their effectiveness.
The event, designed to quickly disseminate the latest findings in a concise and clinically relevant format, drew leading hematologists and oncologists from around the globe. A follow-up event on January 22, 2026, will delve deeper into the implications of these discoveries for everyday clinical practice.
Wissenschaftliches Programm
Table of Contents
Highlights of the American Hematology Congress 2025 on January 22, 2026
Vorsitz & Moderation
Prof. Dr. med. Martin Bentz
17:00 Uhr Begrüßung
Prof. Dr. med. Martin Bentz
17:05 Uhr Prof. Dr. Andreas Reiter
„MDS und MPN“
17:30 Uhr Dr. med. Stefanie Lemnitz
„Myelome“
17:55 Uhr Dr. med. Henriette Huber
„CLL und low grade Lymphome“
18:20 Uhr Prof. Dr. med. Kai Neben
„Aggressive Lymphome“
18:45 Uhr Prof. Dr. med. Mark Ringhoffer
„Akute Leukämien und zelluläre Therapien“
19:05 Uhr Dr. Michael Schatz
„Zusammenfassung“
Vorsitzende und Referenten
Prof. Dr. med. Martin Bentz
Director, Medical Clinic III
Städtisches Klinikum Karlsruhe
Dr. med. Henriette Huber
Senior Physician, Medical Clinic III
Städtisches Klinikum Karlsruhe
Dr. med. Stefanie Lemnitz
Specialist Physician, Medical Clinic III
Städtisches Klinikum Karlsruhe
Prof. Dr. med. Kai Neben
Chief Physician, Clinic for Hematology,
Oncology & Palliative Medicine
Klinikum Mittelbaden, Baden-Baden
Prof. Dr. Andreas Reiter
Executive Senior Physician
III. Medical Clinic for Hematology and Oncology,
UMM Universitätsmedizin Mannheim
Prof. Dr. med. Mark Ringhoffer
Head of the Section “Stem Cell Transplantation
and Cellular Therapy”
Med. Clinic III
Städtisches Klinikum Karlsruhe
Dr. Michael Schatz
Head of the Medical Clinic II
ViDia Kliniken Karlsruhe
Sponsoren
The event received financial support from the following companies:
- Alexion AstraZeneca GmbH (1,500 EUR)
- Amgen GmbH (1,000 EUR)
- AstraZeneca GmbH (1,500 EUR)
- BeOne Medicines Germany GmbH (1,000 EUR)
- Bristol Myers Squibb GmbH Co. KGaA (1,000 EUR)
- GILEAD Sciences GmbH (1,000 EUR)
- GSK GlaxoSmithKline GmbH & Co. KG (750 EUR)
- Incyte Bioscenic Germany GmbH (1,000 EUR)
- Janssen-Cilag GmbH Johnson&Johnson (1,000 EUR)
- Lilly Deutschland GmbH (1,500 EUR)
- MSD Sharp & Dohme GmbH (750 EUR)
- Novartis Pharma GmbH (1,000 EUR)
- Oncopeptides GmbH (750 EUR)
- Otsuka Pharma AG (750 EUR)
- Pfizer Pharma GmbH (500 EUR)
- Roche Pharma AG (800 EUR)
- Servier Deutschland GmbH (1,000 EUR)
As of January 2, 2026
Organisatorische Hinweise
Attendance at the event is free of charge.
Continuing Medical Education Credits
The event has been submitted for certification to the State Medical Chamber of Baden-Württemberg.
Contact Information
Städtisches Klinikum Karlsruhe
Moltkestraße 90, 76133 Karlsruhe
Secretariat of Medical Clinic III
Sonja Klopper-Sommer
Telephone: 0721 974-3001 (from 8:30 AM – 1:00 PM)
Fax: 0721 974-3009
Email
Please respond by fax, email, or post by January 14, 2026.
